Close
Pharmaphorum – BIO Boston 2025 is shaping up to be a year of challenge – but also opportunity – say biotech bosses
pharmaphorum round-up article highlights the sector’s resilience and vision. From smarter, patient-centric trial design to precision-driven development and differentiated #Oncology modalities, the major themes from this year’s BIO convention align perfectly with the bold approach behind Domain’s clinical pipeline.
We are proud to have our leadership team driving key conversations that are shaping the future of #Biotech!